Know Cancer

or
forgot password

Trends of Immunosuppression Therapy and Their Effectiveness in Patients With Liver Transplantation


N/A
20 Years
N/A
Open (Enrolling)
Both
Evidence of Liver Transplantation

Thank you

Trial Information

Trends of Immunosuppression Therapy and Their Effectiveness in Patients With Liver Transplantation


Specific aims are proposed to achieve in this study:

1. To compare graft and patient survival rate, incidence of treatment-related adverse
effects between different patterns of immunosuppression combination among patients
received post-liver transplant care in Kaohsiung Chang Gung Memorial Hospital (KCGMH),
Taiwan.

2. To quantify the long-term health impacts of immunosuppressive regimens on
quality-adjusted life expectancy (QALE), the loss-of-QALE relating to immunosuppression
therapy, and types of transplantation.


Aim 1:

Inclusion Criteria:



- age at liver transplantation is at least 20 years

Aim 2:

Inclusion Criteria:



- age at liver transplantation is at least 20 years

Exclusion Criteria:

- deceased patient

- cannot obtain inform consent

- age <20 years

Type of Study:

Observational

Study Design:

Observational Model: Cohort

Outcome Measure:

incidence of graft and patient mortality, treatment-related complications

Outcome Description:

Patient will be followed from the date of liver transplantation to the occurence of outcome event for 5 years

Outcome Time Frame:

5 years

Safety Issue:

Yes

Principal Investigator

Chien-Ning Hsu, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Kaohsiung Chang Gung Memorial Hospital

Authority:

Taiwan : Food and Drug Administration

Study ID:

102-0582C

NCT ID:

NCT01834690

Start Date:

April 2013

Completion Date:

December 2014

Related Keywords:

  • Evidence of Liver Transplantation
  • Liver transplantation/epidemiology
  • Liver transplantation/pharmacology
  • Health status/drug effects
  • Agents, immunosuppressive agents

Name

Location